Research Vials: Frequently Asked Questions

A research peptide vial contains lyophilized (freeze-dried) peptide powder at pharmaceutical grade purity. Before use, the peptide is reconstituted with bacteriostatic water to create an injectable solution. This format provides maximum stability, flexible concentration control, and cost-effective research. Peptides Pharma vials contain pharmaceutical-grade peptides at >99% purity.

To use a peptide vial: (1) Clean the vial stopper with alcohol, (2) Draw bacteriostatic water into a syringe, (3) Inject water slowly down the side of the vial, (4) Gently swirl until dissolved, (5) Draw your desired dose into an insulin syringe, (6) Administer subcutaneously at the injection site.

Lyophilized peptide vials offer several key advantages: (1) Maximum stability — freeze-dried format extends shelf life to 24+ months. (2) Flexible dosing — reconstitute to your preferred concentration. (3) Cost-effective — lower price per mg than pre-mixed formats. (4) Precise control — use calibrated syringes for exact dosing. (5) Quality assured — >99% HPLC purity with COA included.

Most Peptides Pharma research vials are designed for a 30-day dosing period, with one vial covering a full monthly research cycle. The exception is the Tirzepatide Vial, which is a single-use prefilled vial for once-weekly administration (approximately 4 per month). Each vial type states its intended dosing period clearly.

Yes. All Peptides Pharma research vials should be stored at 2-8°C (standard refrigerator temperature) and protected from direct light. Do not freeze. Proper refrigeration maintains peptide stability and bioactivity throughout the 24-month shelf life and during the active dosing period.

Peptides Pharma research vials use standard vial needles designed for subcutaneous injection. The NAD+ Vial system includes micro-needles. A fresh sterile needle should be used for each injection to maintain sterility and ensure comfortable administration.

Yes. Peptides Pharma research vials undergo 0.22um membrane filtration and gamma ray sterilisation during manufacturing. The vials are factory-sealed in sterile packaging. Users should always use a new sterile needle for each injection and follow standard aseptic technique.

Peptide vials are compact and portable, making them suitable for transport. However, they must remain refrigerated (a cool bag with ice packs is suitable for short journeys). For air travel, check the relevant airline and destination regulations regarding injectable research materials. Keep vials in their original packaging with documentation.

Peptides Pharma offers 10 products across three vial categories: 8 Research Vial system products (BPC-157, TB-500, CJC-1295, Ipamorelin, Tirzepatide, GHK-Cu, Glutathione, and NAD+), 1 Tirzepatide Vial (Tirzepatide 40mg prefilled), and 1 NAD+ Vial system (NAD+ cartridge vial). All are pharmaceutical-grade with >99% purity.

The Peptide Vial System is a multi-dose reusable vial for 30-day daily dosing (8 peptides available). The Tirzepatide Vial is a prefilled, single-use vial for once-weekly Tirzepatide 40mg. The NAD+ Vial System is a reusable aluminium vial with replaceable cartridges for daily NAD+ microdosing. Each format is engineered for its specific dosing protocol.